Neurocrine Biosciences
4 clinical trials · 4 recruiting · INDUSTRY
Trials by Neurocrine Biosciences
RECRUITINGPhase 2NCT07288320
An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current...
The primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving manic symptoms in adults with bipolar I disorder who are...
Sponsor: Neurocrine BiosciencesEnrolling: 1506 locations
Bipolar I DisorderMania
RECRUITINGPhase 3NCT07114874
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
This study will evaluate the long-term safety of NBI-1117568 in adults with schizophrenia.
Sponsor: Neurocrine BiosciencesEnrolling: 80020 locations
Schizophrenia
RECRUITINGPhase 3NCT06963034
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
The primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving behavioral and psychological symptoms of schizophrenia in adults.
Sponsor: Neurocrine BiosciencesEnrolling: 28420 locations
Schizophrenia
RECRUITINGPhase 3NCT07105098
NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
The primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving behavioral and psychological symptoms of schizophrenia in adults.
Sponsor: Neurocrine BiosciencesEnrolling: 2845 locations
Schizophrenia